Subscribe Now

[hb-subscribe]

Trending News

Now enrolling adults with type 1 diabetes for a nighttime hypoglycemia study.

T1D Exchange is helping Zucara Therapeutics recruit for their Phase 2 clinical trial evaluating an investigational drug that may help adults living with T1D who experience nighttime lows.

T1D Exchange is not a sponsor and is not administering this clinical trial, nor are we implying that you will qualify. We are sharing this information with you so you can decide whether or not to seek more information or to participate.

See if You Qualify

CLINICAL TRIAL DETAILS

Zucara Therapeutics, Inc., is conducting a clinical trial to evaluate an investigational medication which may lower the risk of experiencing low glucose levels during the night. 

This clinical trial will help determine how well ZT-01, an investigational drug, works in reducing nighttime hypoglycemia and the safety and tolerability of three dose levels of ZT-01 in adults with T1D.  

Share this information with friends, family, or your doctor:

ELIGIBILITY CRITERIA

Zucara Therapeutics is looking for individuals who:

  • Are between the ages of 18 to 75  
  • Have lived with T1D for at least five years  
  • Have recently experienced low glucose levels during the night.

* The guidelines listed above are the primary eligibility criteria for this study. Only the clinical trial research staff can determine if you meet all eligibility criteria for this study. 

See if you qualify

Step 1: Complete a brief questionnaire to determine if you may be a good fit for this clinical trial.
Step 2: If your answers in the eligibility screener suggest you may qualify, you will be contacted by your local study site coordinator. Your local study site coordinator will ask follow-up questions to confirm your eligibility for this trial. They will also provide additional information about this research opportunity and, if you qualify, give you the option to enroll.
See if You Qualify

To protect your privacy, we will not share your contact information with the study staff unless you sign the Informed Consent Form at the beginning of the eligibility screener.

WHAT TO EXPECT IF YOU ENROLL IN THE CLINICAL TRIAL

  • The study requires six in-person visits and two phone calls over this time period – approximately 16 weeks.
  • The clinical trial research staff will communicate other requirements.
  • Qualified participants will receive payment for time and travel.
See if You Qualify
Sleep Hypoglycemia Study

DIRECTORY OF SITES BY STATE

University of Southern California
Keck School of Medicine
Eastside Center for Diabetes

245 South Fetterly Ave
Suite 22
Los Angeles, CA 90022

LCGK Research

1660 San Carlos Ave
San Carlos, CA 94070

East Coast Institute for Research

8773 Perimeter Park Court
Jacksonville, FL 32216

Suncoast Clinical Research

5604 Gulf Dr
New Port Richey, FL 34652

Hanson Clinical Research Center Inc.

21216 Olean Blvd, Suite 6 & 7
Port Charlotte, FL 33952

Palm Beach Diabetes and Endocrine Specialists
Metabolic Research Institute

1515 North Flagler Dr
Suite 440
West Palm Beach, FL 33401

East Coast Institute for Research

265 Sheraton Blvd, Suite 100
Macon, GA 31210

Indiana Health University Hospital

550 North University Blvd
Indianapolis, IN 46202

University of Kansas Medical Center

3901 Rainbow Boulevard
Kansas City, KS 66160

MedStar Good Samaritan Hospital

5601 Loch Raven Blvd, 2nd floor
Baltimore, MD 21239

Palm Medical Group / Palm Research Centre Inc

9280 West Sunset Rd
Suite 306
Las Vegas, NV 89148

Lucas Research, Inc.

623 North 35th Street
Morehead City, NC 28557

University Diabetes & Endocrine Consultants

5616 Brainerd Rd
Suite 208
Chattanooga, TN 37411

Texas Diabetes and Endocrinology – South Austin Office

5000 Davis Lane
Suite 200
Austin, TX 78749

Southern Endocrinology Associates

1621 North Belt Line Road
Suite A
Mesquite, TX 75149

Diabetes & Glandular Disease Clinic

5107 Medical Dr
San Antonio, TX 78229

NOTE: This site is for US residents only. If you do not live in the United States and are located in Canada, please click on this link to learn more about how you may be able to participate in this trial.

Send this to a friend